During the past decade, Toyama University Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Toyama University Hospital" are "EPP" (2 trials) and "XLP" (2 trials). Many other conditions were trialed in "Toyama University Hospital" in a lesser frequency.

Most popular intervention types in "Toyama University Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "MT-7117" (1 trials), "MT-7117 High Dose" (1 trials), "MT-7117 Low Dose" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Toyama University Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Toyama University Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Toyama University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Toyama University Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".